Frengki Frengki

Mr. Frengki Frengki


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2017 in AcTion: Aceh Nutrition Journal
Verified
Journal Article
Open access
PDF file
NZNoni Zakiah
Noni Zakiah
YYYanuarman Yanuarman
Yanuarman Yanuarman
FFFrengki Frengki
Frengki Frengki
MMMunazar Munazar
Munazar Munazar
For a long period, the therapy of liver diseases that carried out against liver diseases is still a challenge for modern medicine. The drugs used in the treatment of liver diseases such as antiviruses, diuretics, and antibiotics could cause some serious side effects. Annona muricata plants or better known as soursop plant has long been widely used as traditional medicine. This study was aimed to determine the hepatoprotective effects of ethanol extract of soursop (Annona muricata L.) leaves on liver histologist pattern of the mice of Sprague-Dawley thread that exposed to high doses of paracetamol. The dosages of the ethanol extract of soursop leaves of 200 mg/Kg BW, 400 mg/Kg BW and 600 mg/Kg BW orally for 14 days, then 2 hours after induction of final dose, induced with paracetamol 2.5 g/kg BW orally. Furthermore, through the observation of mice liver histologic, the level of damages in mice liver cells, including conditions of hepatocytes, necrosis, pyknocytosis, karyorrhexis, karyolysis were recorded. The results showed that ethanol extract of soursop leaves with a dose of 600 mg/kg BW showed significant hepatoprotective effects characterized by a relatively normal hepatocytes condition after exposure to high doses of paracetamol. The final conclusion was that the ethanol extract of soursop leaves provide hepatoprotective effects.Keywords: Annonamuricata L., hepatoprotective, paracetamol, liver histologySelama ini terapi yang dilakukan terhadap penyakit hati masih merupakan tantangan bagi pengobatan modern. Obat-obat yang biasa digunakan pada pengobatan penyakit hati diantaranya adalah antivirus, diuretic dan antibiotik yang dapat menimbulkan beberapa efek samping yang serius. Tumbuhan Annona muricata (sirsak) telah lama digunakan sebagai obat tradisional yang luas. Penelitian ini bertujuan untuk mengetahui efek hepatoprotektif ekstrak etanol daun sirsak (Annona muricata L.) terhadap gambaran histologis hati tikus putih galur Sprague dawley yang terpapar parasetamol dosis tinggi. Dosis yang digunakan adalah ekstrak etanol daun sirsak (EEDS) dosis 200 mg/kg BB, 400 mg/kg BB dan 600 mg/kg BB per oral selama 14 hari, kemudian 2 jam setelah pemberian dosis akhir, diinduksi dengan parasetamol 2,5 g/kg BB per oral. Selanjutnya dilakukan pengamatan histologi hati tikus, dicatat tingkat kerusakan pada sel hati tikus, meliputi kondisi hepatosit, nekrosis, piknositosis, karioreksis, kariolisis. Hasil penelitian menunjukkan bahwa ekstrak etanol daun sirsak dosis 600 mg/kg BB memperlihatkan efek hepatoprotektif yang signifikan yang ditandai dengan kondisi hepatosit yang relatif normal setelah terpapar dengan dosis tinggi parasetamol. Dari hasil penelitian disimpulkan pemberian ektrak etanol daun sirsak memberikan efek hepatoprotektifKata kunci: Annona muricata L., hepatoprotektif, parasetamol, histologi hati

31 March 2025 in Veterinary World
Verified
Journal Article
Open access
SNSarah Ika Nainggolan
Sarah Ika Nainggolan
RRRajuddin Rajuddin
Rajuddin Rajuddin
RKReno Keumalazia Kamarlis
Reno Keumalazia Kamarlis
MHMuhammad Hambal
Muhammad Hambal
FFFrengki Frengki
Frengki Frengki
Background and Aim: p53 is a critical tumor suppressor protein responsible for regulating the cell cycle and inducing apoptosis. Mutations in the p53 gene, particularly in the DNA-binding domain, are frequently associated with various cancers due to the loss of transcriptional activity. Curcumin and its derivatives have demonstrated potential as p53 enhancers and reactivators of mutant p53. This study employs in silico methods to evaluate the potential of curcumin derivatives to enhance wild-type p53 expression and restore the function of the p53 mutant R273H. Materials and Methods: Curcumin and 20 derivatives were selected from PubChem for computational analysis. Their potential as p53 enhancers was assessed using Quantitative Structure-Activity Relationship (QSAR) analysis. Molecular docking was conducted to determine their binding affinities with wild-type and mutant p53 proteins, followed by molecular dynamics (MD) simulations to evaluate ligand-receptor stability. Pharmacokinetics and toxicity assessments were performed using predictive computational models to evaluate their drug-like properties. Results: QSAR analysis identified hexahydrocurcumin (probable activity [Pa]: 0.837) and tetrahydrocurcumin (Pa: 0.752) as the most potent p53 enhancers. Molecular docking revealed strong binding affinities for curcumin derivatives at key p53 binding residues, particularly through hydrogen bonds with His 273 of the R273H mutant. MD simulations demonstrated that curcumin, bisdemethoxycurcumin, and monodemethylcurcumin stabilized p53 mutant R273H, closely mimicking the structural stability of wild-type p53. Pharmacokinetic analysis indicated favorable absorption, distribution, metabolism, and excretion profiles for most derivatives, with low toxicity predicted for the majority. Conclusion: Curcumin and its derivatives exhibit dual functions as p53 enhancers and reactivators of the p53 mutant R273H. Hexahydrocurcumin and tetrahydrocurcumin emerged as promising compounds with strong bioactivity and favorable pharmacokinetic properties, suggesting their potential as anticancer agents. Further in vitro and in vivo studies are necessary to validate these findings and explore their therapeutic applications. Keywords: curcumin derivatives, in silico analysis, molecular docking, molecular dynamics, p53 enhancer, p53 mutant R273H.

21 June 2024 in Veterinary World
Verified
Journal Article
Open access
FFFarida Farida
Farida Farida
MHMuhammad Hambal
Muhammad Hambal
HVHeni Vanda
Heni Vanda
FFFrengki Frengki
Frengki Frengki
WSWahyu Eka Sari
Wahyu Eka Sari
Background and Aim: The potential of plants as anthelmintics is very large, but there is still very little research conducted in the search for effective, safe, easily obtained, and affordable anthelmintic candidates. Palem putri (Veitchia merrillii) is an ornamental plant that is interesting to study because it is included in the areca nut group which is reported to have strong abilities as anthelmintics. The study aims to evaluate the anthelmintic efficacy of Veitchia merrillii against trematode worms such as Paramphistomum spp. and Fasciola hepatica. Materials and Methods: This research employs both in vitro and computational techniques. An anthelmintic in vitro test was carried out on Paramphistomum spp. worms at concentrations of 10%, 25%, and 40% (gr/v), assessing mortality index as the observable outcome, followed by a histopathological investigation of the deceased worms for tissue and cellular damage evaluation. Seventeen compounds from V. merrillii seeds were studied in silico for their anthelmintic activity against F. hepatica worms using the quantitative structure-activity relationship technique, molecular docking, and Lipinski’s rule analysis for orally administered medication. Results: About 25% and 40% extracts of V. merrillii damaged the tegument organs in the worms. Seventeen compounds in V. merrillii seed extract, on average, yielded a higher anthelmintic index on F. hepatica than praziquantel. Eleven of the 17 compounds exhibit stronger affinity than praziquantel, with routine and gallic acid being the top two ligands (ΔGbinding values: −11.65 kcal/mol and −11.07 kcal/mol, respectively). According to Lipinski’s rule analysis, only routine compounds cannot be orally administered. Conclusion: The seeds of V. merrilli have potential as an anthelmintic agent for Paramphistomum spp. at concentrations of 25%–40% (gr/v). Keywords: Molecular docking, QSAR, Trematoda, Veitchia merillii.

26 May 2021 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
FFFrengki Frengki
Frengki Frengki
DPDeddi P. Putra
Deddi P. Putra
FWFatma Sri Wahyuni
Fatma Sri Wahyuni
DKDaan Khambri
Daan Khambri
VSVivi Sofia
Vivi Sofia

25 May 2022 in Veterinary World
Verified
Journal Article
Open access
MHMuhammad Hambal
Muhammad Hambal
FFFrengki Frengki
Frengki Frengki
WSWahyu Eka Sari
Wahyu Eka Sari
HVHenni Vanda
Henni Vanda
Background and Aim: Angiostrongylus eosinophilic meningitis is caused by larvae of the rat lungworm Angiostrongylus cantonensis. It manifests as meningitis, radiculitis, cranial nerve abnormalities, and encephalitis, which can be fatal. A flavan-3-ol compound isolated from the bark of Calophyllum macrophyllum Scheff. has several medicinal properties, including antioxidant, anti-inflammatory, antidiabetic, and antibacterial activities. This compound is stronger than other types of flavan-3-ols such as catechin. This study aimed to identify the hydroxylation pattern of this flavan-3-ol compound and evaluated its potential as an anti-meningitis drug, using an in silico approach through pharmacophore and molecular docking methods. Materials and Methods: Pharmacokinetic and toxicological data were analyzed and supported by the server http://www. swissadme.ch/index.php and https://tox-new.charite.de/protox_II/index.php. The hydroxylation pattern of the flavan-3-ol compound was identified using shear reagents (MeOH, NaOH, NaOAc, HCl, and AlCl3). The CviR receptor (pdb id.3QP5) was used in the in silico approach, and seven ligands were downloaded from PubChem in "SMILES" format. Results: The spectroscopic analysis conducted using the shear reagents confirmed that the flavan-3-ol compound has a "p-diOH" pattern on the cinnamoyl ring. Pharmacophore analysis revealed this compound "hit" with pharmacophore features, and molecular docking analysis showed that this compound has a strong affinity with both receptors. Conclusion: The flavan-3-ol compound is a potential drug candidate for meningitis caused by pathogenic bacteria and the worm A. cantonensis. This result was supported by the pharmacokinetic profile, which had a very low toxicity level to the host. However, further investigation is required to confirm the data in vitro and in vivo.

3 June 2023 in Jurnal Natural
Verified
Journal Article
Open access
PDF file
FFFrengki Frengki
Frengki Frengki
KAKms M Amin Alqadri
Kms M Amin Alqadri
SASiti Aisyah
Siti Aisyah
HHHennivanda Hennivanda
Hennivanda Hennivanda
Breast cancer is one type of cancer with the highest incidence suffered by women. Doxorubicin is a chemotherapy that is often used as the main chemotherapy and combination chemotherapy, but the use of doxorubicin is often complained of side effects that cause auto resistance. Combination with chemopreventives from natural ingredients has become an option to increase therapeutic response and to minimize side effects and resistance to chemotherapy use. This study aims to screen several active compounds of the phenolic-flavonoid group contained in Moringa leaves (Moringa oleifera, Lam) against NFκβ receptors in silico using a molecular docking technique. The material in the form of “Canonical smiles” data is quercetin, quercetin-3 glycoside (Q3G), rutin, kaempferol, myricetin, isorhamnetin, deoxyelephantopin and doxorubicin which were downloaded from www.pubchem.org and converted to 3D structures using MOE software. While the 3D structure of the receptor (1VKX) was downloaded from www.rscb.org. The results of the docking of the active compounds contained in Moringa leaves (Moringa oleifera, Lam) showed a fairly strong affinity by releasing energy when forming a ligand-receptor complex. Quercetin 3-glycoside has the best potential as an NF inhibitor with an affinity of -14.23 kcal/mol. Quercetin 3-glycoside also has a good pharmacokinetic profile with low toxicity. While the phenolic-flavonoid compounds contained in other Moringa leaves are only able to reduce the affinity of doxorubicin for the NF receptor by changing the "site binding" conformation of the receptor. In conclusion, quercetin 3-glycoside deserves to be a drug candidate or a companion to the chemotherapy of doxorubicin.